PRINCIPAL FINANCIAL GROUP INC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 160 filers reported holding ACORDA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$387,000
-55.8%
414,579
-3.5%
0.00%
-100.0%
Q4 2019$876,000
-21.0%
429,468
+11.2%
0.00%0.0%
Q3 2019$1,109,000
-55.9%
386,301
+17.9%
0.00%
-50.0%
Q2 2019$2,514,000
-41.8%
327,706
+0.9%
0.00%
-50.0%
Q1 2019$4,316,000
-15.4%
324,727
-0.8%
0.00%
-20.0%
Q4 2018$5,099,000
-20.3%
327,281
+0.6%
0.01%
-16.7%
Q3 2018$6,395,000
-40.4%
325,440
-12.9%
0.01%
-40.0%
Q2 2018$10,721,000
+23.2%
373,538
+1.5%
0.01%
+25.0%
Q1 2018$8,703,000
+13.5%
367,973
+2.9%
0.01%
+14.3%
Q4 2017$7,667,000
-8.2%
357,437
+1.2%
0.01%
-12.5%
Q3 2017$8,352,000
+19.0%
353,171
-0.9%
0.01%
+14.3%
Q2 2017$7,018,000
-5.6%
356,253
+0.6%
0.01%
-22.2%
Q1 2017$7,435,000
+16.5%
354,029
+4.3%
0.01%
+12.5%
Q4 2016$6,381,000
-8.5%
339,433
+1.6%
0.01%
-11.1%
Q3 2016$6,976,000
-15.7%
334,104
+3.0%
0.01%
-25.0%
Q2 2016$8,276,000
-0.2%
324,468
+3.5%
0.01%0.0%
Q1 2016$8,295,000
-33.5%
313,616
+7.5%
0.01%
-36.8%
Q4 2015$12,476,000
+74.4%
291,640
+8.1%
0.02%
+72.7%
Q3 2015$7,152,000
-20.0%
269,802
+0.5%
0.01%
-15.4%
Q2 2015$8,945,000
-1.0%
268,378
-1.1%
0.01%0.0%
Q1 2015$9,032,000
-15.6%
271,402
+3.7%
0.01%
-23.5%
Q4 2014$10,699,000
+21.6%
261,787
+0.8%
0.02%
+13.3%
Q3 2014$8,799,000
-0.4%
259,690
-0.9%
0.02%0.0%
Q2 2014$8,834,000
-11.4%
262,061
-0.4%
0.02%
-16.7%
Q1 2014$9,973,000
+15.8%
263,082
-10.8%
0.02%
+12.5%
Q4 2013$8,610,000
+6.7%
294,845
+25.2%
0.02%
-5.9%
Q3 2013$8,071,000
+7.2%
235,421
+3.2%
0.02%0.0%
Q2 2013$7,528,000228,2000.02%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,045,400$21,953,00012.28%
SCOPIA CAPITAL MANAGEMENT LP 5,568,306$116,934,0002.16%
GREAT POINT PARTNERS LLC 432,500$9,083,0001.80%
Consonance Capital Management LP 619,419$13,008,0001.36%
RA Capital Management 489,828$10,286,0001.26%
Ghost Tree Capital, LLC 300,000$6,300,0001.17%
DLD Asset Management, LP 281,900$5,920,0000.95%
DLD Asset Management, LP 281,900$5,914,0000.95%
Worth Venture Partners, LLC 36,650$770,0000.68%
Malaga Cove Capital, LLC 51,013$939,0000.57%
View complete list of ACORDA THERAPEUTICS INC shareholders